TickerFacts.

Exagen Inc. (XGN): Operating Income

Annual figures by period end, from SEC filings.

-$14.07M
Year ended 2025-12-31
-$13.21M
Trailing 12 months to 2026-06-30
2018-12-31: -$4.88M2019-12-31: -$9.30M2020-12-31: -$15.19M2021-12-31: -$24.07M2022-12-31: -$46.05M2023-12-31: -$22.84M2024-12-31: -$13.64M2025-12-31: -$14.07M-$14.07M
2018-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$14.07Mn/m2026-03-10, From 2025-01-01
2024-12-31-$13.64Mn/m2026-03-10, From 2024-01-01
2023-12-31-$22.84Mn/m2025-03-11, From 2023-01-01
2022-12-31-$46.05Mn/m2024-03-18, From 2022-01-01
2021-12-31-$24.07Mn/m2023-03-20, From 2021-01-01
2020-12-31-$15.19Mn/m2022-03-22, From 2020-01-01
2019-12-31-$9.30Mn/m2021-03-16, From 2019-01-01
2018-12-31-$4.88Mn/a2020-03-25, From 2018-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Exagen Inc. (XGN)2025-12-31-$14.07Mn/m
Personalis, Inc. (PSNL)2025-12-31-$88.06Mn/m
Biodesix Inc (BDSX)2025-12-31-$27.87Mn/m
CapForce Inc. (CFOR)2025-12-31$24.03Mn/m
GRAIL, Inc. (GRAL)2025-12-31-$562.16Mn/m
American Shared Hospital Services (AMS)2025-12-31-$3.59Mn/m
BillionToOne, Inc. (BLLN)2025-12-31$16.02Mn/m
Fulgent Genetics, Inc. (FLGT)2025-12-31-$91.10Mn/m
Castle Biosciences Inc (CSTL)2025-12-31-$42.81Mn/m

Compare XGN, PSNL, BDSX, CFOR side by side · Screen every company in Services-Medical Laboratories ↗